EE355 Budget Impact Model of a New rFVIIa (Eptacog Beta), for the On-Demand Treatment of Spontaneous Bleeding Events and Surgical Bleedings Among Hemophilia Patients with Inhibitors: A Payer Perspective From UK
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.601
https://www.valueinhealthjournal.com/article/S1098-3015(22)02805-4/fulltext
Title :
EE355 Budget Impact Model of a New rFVIIa (Eptacog Beta), for the On-Demand Treatment of Spontaneous Bleeding Events and Surgical Bleedings Among Hemophilia Patients with Inhibitors: A Payer Perspective From UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02805-4&doi=10.1016/j.jval.2022.09.601
First page :
Section Title :
Open access? :
No
Section Order :
10132